Site Search
Professionals 769 results
Capabilities 90 results
Practice Area
Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial.
Practice Area
For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future.
Practice Area
Securities, M&A & Corporate Governance Litigation
In today’s market, litigators with experience in securities, corporate governance, and M&A-related (collectively, “securities litigation”) matters need to leverage their broad experience to serve as both advocate and as counsel and strategist, focused on helping clients to overcome not just a legal issue but a collective business problem. Given the frequent interplay between things such as corporate-control transactions, public offerings, activist shareholders, the use of complex derivatives and other financial instruments, bad news impacting stock performance, regulatory inquiries and investigations, and insurance coverage, strategic and tactical litigation decisions can have a wide-ranging impact on the success of a given transaction, as well as on companies, their boards, senior management, and advisors.
Experience 505 results
Experience
|May 1, 2026
Forefront Tech Holdings Acquisition Corp $100,000,000 Initial Public Offering
Winston & Strawn LLP served as legal counsel to Forefront Tech Holdings Acquisition Corp in connection with its $100,000,000 initial public offering. The Company priced 10,000,000 units at a price of $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustments.
Experience
|April 29, 2026
KeHE Distributors, LLC - $500.0 Million Senior Secured Notes Offering
Winston & Strawn, LLC represented KeHE Distributors, LLC, a leading pure-play natural and organic, specialty and fresh food distribution company in North America in connection with a Rule 144A/Reg. S offering of $500 million aggregate principal amount of 7.125% senior secured notes due 2033 issued by KeHE Distributors, LLC, KeHE Finance Corp. and NextWave Distribution, Inc. Proceeds from the offering were used to partially repay amounts outstanding under the company's existing ABL facility and pay related fees and expenses.
Experience
|April 28, 2026
Winston & Strawn LLP Paris advised the management team of TRIGO, a global leader in quality management services for the transport sector, in connection with Montyon Capital’s acquisition of a majority stake and the management buy-in.
Insights & News 7,937 results
Recognitions
|May 18, 2026
|Less Than 1 Min Read
Nimalka Wickramasekera Named to Los Angeles Times’ 2026 Legal Visionaries List
Winston & Strawn Intellectual Property Practice Co-Chair Nimalka Wickramasekera was included on the Los Angeles Times’ 2026 Legal Visionaries list. This series celebrates lawyers who have demonstrated an ongoing commitment to fostering positive change in the legal community, outstanding leadership, and a track record of success in their field.
False Claims Act Playbook
|May 14, 2026
|3 Min Read
DOJ Launches FOCUS Initiative, Signaling Increasingly Data-Driven Era of FCA Enforcement
On April 30, 2026, the U.S. Department of Justice’s Civil Division announced a new initiative called the Fraud Oversight through Careful Use of Statistics (“FOCUS”) initiative, aimed at strengthening DOJ’s engagement with so‑called “data miner” whistleblowers who bring False Claims Act (FCA) qui tam actions based on publicly available government data, rather than insider knowledge.
In the Media
|May 13, 2026
|1 Min Read
Alexander Ott Discusses ITC Litigation Funding Disclosure Proposal with Law360
Winston & Strawn partner Alexander Ott was quoted in a Law360 article discussing the U.S. International Trade Commission (ITC)’s proposed rule requiring disclosure of litigation funding in Section 337 intellectual property investigations. The proposed rule would require parties appearing before the ITC to disclose litigation funding arrangements and entities with financial interests or authority over litigation and settlement decisions. According to the article, the ITC stated that the information could help identify conflicts of interest and provide greater clarity in Section 337 investigations.
Other Results 151 results
Law Glossary
What Is Advertising Litigation?
Advertising litigation is defined as the legal area that covers false or deceptive advertising cases. Lawsuits may be brought by government agencies or corporate competitors based on the Lanham Act—a law that specifically deals with false advertising. The Act outlines how an advertisement can be deemed false. The Federal Trade Commission (FTC) has the ability to file lawsuits to halt deceptive advertising claims. The U.S. Food and Drug Administration may also pursue advertising litigation against violators of government regulations. Companies may be called on to substantiate their advertising claims, whether these are made in print or online.
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation.